Press release
Chronic Idiopathic Myelofibrosis Market foreseen to Grow Exponentially Over 2025
Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/toc/21349
The market of chronic idiopathic myelofibrosis is majorly driven by consistent efforts of key players to develop new and effective therapeutics. In addition, strategic collaboration and acquisition adopted by key players will further act as a driving factor for this market. For example, in May 2010, S-BIO Pte Ltd. and Onyx Pharmaceuticals, Inc. collaborated to expand their license commercialization agreement for S-BIO Pte Ltd’s JAK2 inhibitors (SB1518 and SB1578). Thus, these types of collaboration will build healthy platform to grow chronic idiopathic myelofibrosis market. Large number of therapeutics under clinical study would further augment the market growth. However, the exact cause and mechanism of action of this disorder is still unknown. Thus, introduction of novel therapeutics that enables to eliminate all symptoms of the disorder became difficult task for key players that will restrain the market growth. In addition, low incidence rate of this disease will further restrain the market growth. For example, according to Leukemia & Lymphoma Society, myelofibrosis is a rare bone marrow disorder and the incidence of this disease is continuously decreasing every year. Thus, decreasing number of patients affects chronic idiopathic myelofibrosis restrain the market growth in future. The market of chronic idiopathic myelofibrosis is also witnessing low growth due to discontinuation of phase III clinical study of several drugs. For example, in November 2013, Sanofi SA announced discontinuation of JAK2 inhibitor fedratinib clinical trial. This drug has completed pivotal phase III clinical study and is indicated for the treatment of myeloproliferative neoplasms.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/21349
Geographically, North America dominates the global chronic idiopathic myelofibrosis market. High incidence of chronic idiopathic myelofibrosis coupled with high demand of therapeutics for idiopathic myelofibrosis will drive the growth of the market. Europe is considered as the second largest market of chronic idiopathic myelofibrosis. Large number of key players and increasing demand of treatment fuels the growth of chronic idiopathic myelofibrosis market in Europe. Asia-Pacific region is considered as an emerging market for chronic idiopathic myelofibrosis due to increasing interest of key players to market new and effective therapeutics in this region. Growing awareness for chronic idiopathic myelofibrosis among the patient population will further stimulate the growth of the market in Asia-Pacific region.
Various key players dominating the global chronic idiopathic myelofibrosis market comprises S-BIO Pte Ltd, YM BioSciences, Inc., Sanofi AS, Onyx Pharmaceuticals, Inc. and others.
Read Report Overview @ https://www.persistencemarketresearch.com/market-research/chronic-idiopathic-myelofibrosis-market.asp
ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Idiopathic Myelofibrosis Market foreseen to Grow Exponentially Over 2025 here
News-ID: 901842 • Views: …
More Releases from Persistence Market Research
Retail Glass Packaging Market Projected to Reach US$77.0 Billion by 2032 at 5.3% …
The retail glass packaging market continues to play a crucial role in the global packaging ecosystem, particularly across food, beverage, cosmetics, and pharmaceutical retail channels. Glass packaging remains a preferred solution due to its premium appearance, chemical inertness, recyclability, and ability to preserve product integrity. As consumers increasingly prioritize sustainability, safety, and high quality packaging, retail glass packaging has regained strategic importance across both developed and emerging economies. Brands are…
Quinoa Market to Reach $2.5B by 2033, Driven by Rising Health-Conscious Trends
The global quinoa market is projected to experience substantial growth over the forecast period, driven by increasing consumer awareness of healthy and nutrient-rich food options. The market size is estimated at US$ 1.3 billion in 2026 and is expected to reach US$ 2.5 billion by 2033, representing a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.
Quinoa's rich nutritional profile, including high protein content, essential amino acids, vitamins,…
Cold-Pressed Oil Market to Reach $53.1B by 2033 Driven by Health-Conscious Deman …
The global cold-pressed oil market is poised for significant expansion over the next decade, driven by rising health awareness, demand for natural and minimally processed products, and increasing adoption of plant-based dietary patterns. Current market estimates indicate that the market is expected to reach a valuation of US$ 35.8 billion in 2026, with projections pointing toward US$ 53.1 billion by 2033. This represents a compound annual growth rate (CAGR) of…
Molded Case Circuit Breaker Market to Reach US$ 15.1 Billion by 2033 - Persisten …
The molded case circuit breaker market plays a critical role in the global power distribution and electrical protection ecosystem. Molded case circuit breakers commonly referred to as MCCBs are essential components in low voltage electrical systems where they provide overload protection short circuit protection and isolation capabilities. These devices are widely used across residential commercial and industrial infrastructures to ensure electrical safety reliability and operational continuity. As energy demand continues…
More Releases for Idiopathic
Idiopathic Pulmonary Fibrosis Market Size & Share Analysis
The new report published by The Business Research Company, titled Idiopathic Pulmonary Fibrosis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the idiopathic pulmonary fibrosis market size has grown strongly in recent years. It will grow from $3.89…
Charting New Frontiers: Idiopathic Gastroparesis Drugs Market Dynamics
The Idiopathic Gastroparesis Drugs Market 𝐑𝐞𝐩𝐨𝐫𝐭 dissects the complex fragments of the Market in an easy-to-read manner. This report covers drivers, restraints, challenges, and threats in the Idiopathic Gastroparesis Drugs Market to understand the overall scope of the Market in a detailed yet concise manner.
Additionally, the Market report covers the top-winning strategies implemented by major industry players and technological advancements that steer the growth of the Market.
𝐂𝐥𝐚𝐢𝐦 𝐲𝐨𝐮𝐫 𝐂𝐨𝐩𝐲…
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,…
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth …
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria).
R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. In…
Global Idiopathic Scoliosis Treatment Market Size by Type (Infantile Idiopathic, …
Global Idiopathic Scoliosis Treatment Market Research report provides vital information related to the overall market and forecast from 2019 to 2026. This report includes the in-depth analysis of market size, share, growth, trends and regional demand and top layers the Idiopathic Scoliosis Treatment Market. The major players dominating the market are focused upon throughout the by analyzing their revenue, their business summary, product segmentation along with the latest developments.
Get Sample…
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation…
